MyndYou

News

An artificial intelligence-based tool has shown impressive results in raising colorectal cancer screening rates in underserved populations.

News

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.